SCHEMBL6162084

SCHEMBL6162084

Cc1cc(-c2ccc(F)cc2)ccc1N1CCNCC1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 9/20 0.57
HTR7 P34969 7/20 0.57
HTR3A P46098 7/20 0.55
HTR3E A5X5Y0 1/20 0.55
HTR3B O95264 1/20 0.55
HTR3D Q70Z44 1/20 0.55
HTR3C Q8WXA8 1/20 0.55
ADRB1 P08588 2/20 0.51
HTR2B P41595 2/20 0.51
HTR6 P50406 2/20 0.51
HTR1D P28221 1/20 0.47
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDR P35968 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30609639 0.87 HTR3A (0.61) HTR1AHTR7HTR3AHTR3EHTR3B
SCHEMBL706971 0.87 HTR3A (0.61) HTR1AHTR7HTR3AHTR3EHTR3B
SCHEMBL6560075 0.86 ADRB1 (0.62) HTR1AHTR7HTR3AHTR3EHTR3B
Hydrochloric Acid SCHEMBL709707 0.85 HTR3A (0.59) HTR1AHTR7HTR3AHTR3EHTR3B
SCHEMBL6162708 0.83 L3MBTL1 (0.55) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL27477678 0.78 HTR1A (0.54) HTR1AHTR7HTR3AHTR2BHTR6
SCHEMBL4238177 0.77 ADRB1 (0.58) HTR1AHTR7HTR3AHTR3EHTR3B
SCHEMBL255197 0.76 HTR3A (0.67) HTR1AHTR7HTR3AHTR3EHTR3B
SCHEMBL6160209 0.76 HTR7 (0.60) HTR1AHTR7HTR3AHTR3EHTR3B
Hydrochloric Acid SCHEMBL2534803 0.75 HTR3A (0.68) HTR1AHTR7HTR3AHTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0755923-B1 Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor DAIICHI SUNTORY PHARMA CO LTD (JP) 2005-05-04 EP disclosed
US-6469010-B1 COMPOSITION ALSO FOR ALLEVIATION OR TREATMENT OF SYMPTOMS DERIVED FROM SEIZURES, EPILEPSY AND MIGRAINE HEADACHES, AND SUPPRESSION OF CALCIUM ION OVERLOAD SUNTORY LIMITED (JP) 2002-10-22 US disclosed
EP-0755923-A1 AMELIORANT OR REMEDY FOR SYMPTOMS CAUSED BY ISCHEMIC DISEASES AND COMPOUNDS USEFUL THEREFOR SUNTORY LIMITED (JP) 1997-01-29 EP disclosed